Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

The second to fourth digit ratio in patients with congenital IGF-1 Deficiency.

Uchitel Y, Kauli R, Konen O, Lilos P, Laron Z.

Anthropol Anz. 2019 Feb 28. doi: 10.1127/anthranz/2019/0960. [Epub ahead of print]

PMID:
30816406
2.

A Novel Variant c.97C>T of the Growth Hormone Releasing Hormone Receptor Gene Causes Isolated Growth Hormone Deficiency Type Ib

Galli-Tsinopoulou A, Kotanidou EP, Kleisarchaki AN, Kauli R, Laron Z.

J Clin Res Pediatr Endocrinol. 2018 Jul 31;10(3):284-288. doi: 10.4274/jcrpe.5188. Epub 2018 Feb 28.

3.

IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.

Laron Z, Kauli R, Lapkina L, Werner H.

Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:123-133. doi: 10.1016/j.mrrev.2016.08.002. Epub 2016 Aug 5. Review.

PMID:
28528685
4.

Genetic Mutations, Birth Lengths, Weights and Head Circumferences of Children with IGF-I Receptor Defects. Comparison with other Congenital Defects in the GH/IGF-I axis.

Essakow JL, Lauterpacht A, Lilos P, Kauli R, Laron Z.

Pediatr Endocrinol Rev. 2016 Sep;14(1):19-26. doi: 10.17458/PER.2016.ELLKL.GeneticMutations. Review.

PMID:
28508613
5.

Growth, development, puberty and adult height of patients with congenital multiple pituitary hormone deficiencies.

Haim-Pinhas H, Kauli R, Lilos P, Laron Z.

Growth Horm IGF Res. 2016 Apr;27:46-52. doi: 10.1016/j.ghir.2016.01.004. Epub 2016 Feb 19.

PMID:
26947989
6.

Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.

Laron Z, Kauli R.

Growth Horm IGF Res. 2016 Jun;28:53-6. doi: 10.1016/j.ghir.2015.08.004. Epub 2015 Aug 18.

PMID:
26307357
7.

Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency.

Smuel K, Kauli R, Lilos P, Laron Z.

Growth Horm IGF Res. 2015 Aug;25(4):182-8. doi: 10.1016/j.ghir.2015.05.001. Epub 2015 May 12.

PMID:
26077773
8.

Biphasic response of subscapular skinfold thickness to hGH or IGF-1 administration to patients with congenital IGHD, congenital MPHD and Laron syndrome.

Bisker-Kassif O, Kauli R, Lilos P, Laron Z.

Obes Res Clin Pract. 2014 Jan-Feb;8(1):e55-62. doi: 10.1016/j.orcp.2012.11.001.

PMID:
24548577
9.

Differential effects of hGH and IGF-I on body proportions.

Laron Z, Silbergeld A, Kauli R.

Anthropol Anz. 2012 Jul;69(3):255-9.

PMID:
22928349
10.

Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.

Laron Z, Iluz M, Kauli R.

Growth Horm IGF Res. 2012 Apr;22(2):49-52. doi: 10.1016/j.ghir.2012.02.005. Epub 2012 Mar 11. Review.

PMID:
22414926
11.
12.

Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.

Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.

J Clin Endocrinol Metab. 2001 Sep;86(9):4127-32.

PMID:
11549638
13.

Longitudinal analysis of growth over the first 3 years of life in Turner's syndrome.

Even L, Cohen A, Marbach N, Brand M, Kauli R, Sippell W, Hochberg Z.

J Pediatr. 2000 Oct;137(4):460-4.

PMID:
11035821
14.

Experience with cyproterone acetate in the treatment of precocious puberty.

Laron Z, Kauli R.

J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:805-10. Review.

PMID:
10969925
15.

Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.

Kauli R, Zaizov R, Lazar L, Pertzelan A, Laron Z, Galatzer A, Phillip M, Yaniv Y, Cohen IJ.

Isr Med Assoc J. 2000 Feb;2(2):158-63.

16.

Cirrhosis in a child with hypothalamic syndrome and central precocious puberty treated with cyproterone acetate.

Garty BZ, Dinari G, Gellvan A, Kauli R.

Eur J Pediatr. 1999 May;158(5):367-70.

PMID:
10333116
17.

Growth and developmental follow-up forms.

Laron Z, Pertzelan A, Kauli R.

J Pediatr Endocrinol Metab. 1998 Mar-Apr;11(2):283-4. No abstract available.

PMID:
9642646
19.

High prevalence of abnormal adrenal response in girls with central precocious puberty at early pubertal stages.

Lazar L, Kauli R, Bruchis C, Nordenberg J, Galatzer A, Pertzelan A.

Eur J Endocrinol. 1995 Oct;133(4):407-11.

PMID:
7581962
20.

Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response.

Lazar L, Kauli R, Bruchis C, Nordenberg J, Galatzer A, Pertzelan A.

Eur J Endocrinol. 1995 Oct;133(4):403-6.

PMID:
7581961
21.

Final height of girls with Turner's syndrome: correlation with karyotype and parental height.

Cohen A, Kauli R, Pertzelan A, Lavagetto A, Roitmano Y, Romano C, Laron Z.

Acta Paediatr. 1995 May;84(5):550-4.

PMID:
7633152
22.

Central precocious puberty: evaluation by neuroimaging.

Kornreich L, Horev G, Blaser S, Daneman D, Kauli R, Grunebaum M.

Pediatr Radiol. 1995;25(1):7-11.

PMID:
7761174
24.

Hearing impairment in idiopathic hypoparathyroidism and pseudohypoparathyroidism.

Garty BZ, Daliot D, Kauli R, Arie R, Grosman J, Nitzan M, Danon YL.

Isr J Med Sci. 1994 Aug;30(8):587-91.

PMID:
8045737
25.

Social, educational and vocational status of 48 young adult females with gonadal dysgenesis.

Aran O, Galatzer A, Kauli R, Nagelberg N, Robicsek Y, Laron Z.

Clin Endocrinol (Oxf). 1992 Apr;36(4):405-10.

PMID:
1424173
26.

Myopathy associated with ketoconazole treatment.

Garty BZ, Kauli R, Livni E, Laron Z, Nitzan M.

Am J Dis Child. 1991 Sep;145(9):970-1. No abstract available.

PMID:
1877574
27.

New findings in a patient with Dubowitz syndrome: velopharyngeal insufficiency and hypoparathyroidism.

Lerman-Sagie T, Merlob P, Shuper A, Kauli R, Kozokaro Z, Grunebaum M, Mimouni M.

Am J Med Genet. 1990 Oct;37(2):241-3.

PMID:
2248292
28.

Alopecia universalis in autoimmune polyglandular syndrome type I.

Garty BZ, Kauli R.

West J Med. 1990 Jan;152(1):76-7. No abstract available.

29.

Conclusions: a consensus statement on growth hormone therapy.

Rosenfeld R, Hochberg Z, Albertsson-Wikland K, Gluckman PD, Kastrup K, Kauli R, Pescovitz OH, Price DA, Ranke MB, Rappaport R, et al.

Acta Paediatr Scand Suppl. 1990;367:177-8. Review. No abstract available.

PMID:
2220383
31.

Hepatitis associated with propylthiouracil treatment.

Garty BZ, Kauli R, Ben-Ari J, Lubin E, Nitzan M, Laron Z.

Drug Intell Clin Pharm. 1985 Oct;19(10):740-2.

PMID:
4053978
32.

Delayed puberty and hypoplastic uterus associated with hyperprolactinemia: successful treatment with bromocriptine.

Kauli R, Schoenfeld A, Ovadia Y, Math S, Assa S, Laron Z.

Horm Res. 1985;22(1-2):68-73.

PMID:
4029882
33.

Premature thelarche--natural history and sex hormone secretion in 68 girls.

Ilicki A, Prager Lewin R, Kauli R, Kaufman H, Schachter A, Laron Z.

Acta Paediatr Scand. 1984 Nov;73(6):756-62.

PMID:
6240890
34.

Intellectual function of girls with precocious puberty.

Galatzer A, Beth-Halachmi N, Kauli R, Laron Z.

Pediatrics. 1984 Aug;74(2):246-9.

PMID:
6462822
35.

Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience.

Kauli R, Pertzelan A, Ben-Zeev Z, Lewin RP, Kaufman H, Schally AM, Schally AV, Laron Z.

Clin Endocrinol (Oxf). 1984 Apr;20(4):377-87.

PMID:
6232020
36.

[Congenital hypothyroidism due to athyreosis].

Lewinger Z, Kauli R, Galatzer A, Laron Z.

Harefuah. 1983 Oct 2;105(7):149-51. Hebrew. No abstract available.

PMID:
6671589
37.

Primary gonadal failure and precocious adrenarche in a boy with Prader-Labhart-Willi syndrome.

Garty B, Shuper A, Mimouni M, Varsano I, Kauli R.

Eur J Pediatr. 1982 Nov;139(3):201-3.

PMID:
7160409
38.

[Sexual development in the Prader-Labhart-Willi syndrome].

Garty B, Kauli R.

Harefuah. 1982 Jul;103(1-2):28-9. Hebrew. No abstract available.

PMID:
7160750
39.

Effect of anorexia nervosa on gonadotrophin secretion in a patient with gonadal dysgenesis.

Kauli R, Gurewitz R, Galazer A, Prager-Lewin R, Gil-Ag I, Laron Z.

Acta Endocrinol (Copenh). 1982 Jul;100(3):363-8.

PMID:
6810617
40.
41.

Adrenocortical function in children with precocious sexual development during treatment with cyproterone acetate.

Stivel MS, Kauli R, Kaufman H, Laron Z.

Clin Endocrinol (Oxf). 1982 Feb;16(2):163-9.

PMID:
6279337
42.

D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty.

Laron Z, Kauli R, Zeev ZB, Comaru-Schally AM, Schally AV.

Lancet. 1981 Oct 31;2(8253):955-6.

PMID:
6117727
43.

Keratopathy associated with hypoparathyroidism and Addison's disease.

Nissenkorn I, Yassur Y, Gilad E, Laron Z, Kauli R, Ben-Sira I.

J Pediatr Ophthalmol Strabismus. 1981 Mar-Apr;18(2):28-30.

PMID:
7241303
44.

Prolactin deficiency, obesity, and enlarged testes--a new syndrome?

Roitman A, Assa S, Kauli R, Laron Z.

Arch Dis Child. 1980 Aug;55(8):647-9.

45.
46.

End-organ resistance to 1,25-dihydroxycholecalciferol.

Liberman UA, Samuel R, Halabe A, Kauli R, Edelstein S, Weisman Y, Papapoulos SE, Clemens TL, Fraher LJ, O'Riordan JL.

Lancet. 1980 Mar 8;1(8167):504-6.

PMID:
6102232
47.

[Comparison between growth hormone secretion during sleep and provocative tests in children and adolescents].

Gurewitz R, Cader Y, Kauli R, Keret R, Laron Z.

Harefuah. 1980 Jan 15;98(2):53-6. Hebrew. No abstract available.

PMID:
7390280
48.

XY gonadal dysgenesis associated with hGH and gonadotrophin deficiencies.

Kauli R, Pertzelan A, Prager-Lewin R, Maimon Z, Ovadia J, Laron Z.

Clin Genet. 1979 May;15(5):369-76.

PMID:
571777
49.

Effect of human growth hormone therapy on head circumference in children with hypopituitarism.

Laron Z, Roitman A, Kauli R.

Clin Endocrinol (Oxf). 1979 Apr;10(4):393-9.

PMID:
476974
50.

Linear growth in hypopituitary patients treated with hGH after age fifteen.

Pertzelan A, Adler-Bier M, Kauli R, Josefsberg Z, Grunebaum M, Horodniceanu C, Laron Z.

Acta Paediatr Scand Suppl. 1979;277:69-74.

PMID:
295569

Supplemental Content

Support Center